International Stem Cell (ISCO) Share-based Compensation (2016 - 2025)
Historic Share-based Compensation for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $63000.0.
- International Stem Cell's Share-based Compensation fell 3700.0% to $63000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $324000.0, marking a year-over-year decrease of 3467.74%. This contributed to the annual value of $466000.0 for FY2024, which is 43.1% up from last year.
- According to the latest figures from Q3 2025, International Stem Cell's Share-based Compensation is $63000.0, which was down 3700.0% from $61000.0 recorded in Q2 2025.
- International Stem Cell's Share-based Compensation's 5-year high stood at $234000.0 during Q1 2021, with a 5-year trough of $61000.0 in Q2 2025.
- In the last 5 years, International Stem Cell's Share-based Compensation had a median value of $109000.0 in 2022 and averaged $115631.6.
- In the last 5 years, International Stem Cell's Share-based Compensation tumbled by 6111.11% in 2022 and then skyrocketed by 2685.19% in 2024.
- International Stem Cell's Share-based Compensation (Quarter) stood at $120000.0 in 2021, then dropped by 9.17% to $109000.0 in 2022, then grew by 19.27% to $130000.0 in 2023, then dropped by 23.08% to $100000.0 in 2024, then crashed by 37.0% to $63000.0 in 2025.
- Its last three reported values are $63000.0 in Q3 2025, $61000.0 for Q2 2025, and $100000.0 during Q1 2025.